Patent · US Active

Integrase inhibitors

US8008287B2 · kind B2 · utility

1Cited by
9References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2007
Grant dateAug 30, 2011
Priority date—
Expiry dateNov 18, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.